
Opinion|Videos|October 16, 2024
Faricimab for DME: Durability and Patient Outcomes
Key Takeaways
Dante J Pieramici, MD, shifts the conversation to diabetic macular edema (DME) and the promising drying and anatomical results from an open-label long-term extension trial.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
2
Diabetes Technology at a Turning Point: What’s New and What’s Next, With Rachael Sood, NP
3
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
4
5 Hepatology Headlines You Missed in May 2026
5






















































